Clinical Trial: Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377786) titled 'Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.' on Jan. 22.

Brief Summary: This study aims to evaluate the prognostic values of platelet indices and inflammatory markers in patients with HELLP syndrome as:- :-Primary outcome To investigate prognostic values of platelet indices and. . inflammatory markers in HELLP syndrome patients as main indices including (NLR-PLR-MPV-PDW and RDW). .

-Secondary outcome. Evaluation complications of HELLP syndrome including. .

* Maternal complication:- eclampsia, disseminated intravascular coagulation (DIC), liver rupture, placental abruptio...